PROTEUS logo — Proteus, an interdisciplinary research collaboration based i...

PROTEUS

Proteus, an interdisciplinary research collaboration based in Edinburgh, is revolutionizing lung disease treatment in ICUs.

Founded 2014 United Kingdom Edinburgh, United Kingdom Grant Total: $1.12M Health Care

General Information

Company Name PROTEUS
Founded Year 2014
Location United Kingdom Edinburgh, United Kingdom
Industries Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with PROTEUS. To contact PROTEUS, visit proteus.ac.uk.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PROTEUS compare?

A PDF of PROTEUS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PROTEUS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PROTEUS

PROTEUS is an interdisciplinary research collaboration revolutionizing lung disease treatment in ICUs, based in Edinburgh, United Kingdom. Situated at the Queen's Medical Research Institute at the University of Edinburgh, Proteus has received funding from EPSRC, the Welcome Trust, and three other partner universities. It is among the "Powered by CARB-X" portfolio. Founded in 2014, Proteus has assembled a team of scientists, engineers, and physicians from the Universities of Edinburgh, Bath, and Heriot-Watt, as well as several industrial partners with the objective of revolutionizing the identification and management of lung diseases in the Intensive Care Unit, where patients are most susceptible to respiratory failure. The last investment of $1.12M grant was received on 17 March 2017 from CARB-X. This innovative approach to tackling critical healthcare challenges holds promise for significant impact in the industry.

Business keywords: interdisciplinary research, lung disease, ICU treatment, medical research, University of Edinburgh, academic collaboration, respiratory failure, biomedical engineering, clinical research, medical innovation, critical care, scientific collaboration, EPSRC funding, Welcome Trust funding, CARB-X portfolio

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $1.12M 1
CARB-X
17 Mar 2017

PROTEUS Alternatives & Competitors

View All Alternatives
PROTEUS vs
Invizius
Invizius United Kingdom

Fighting Inflammation at its Source

Series B
15 employees
Biotechnology, Health Care
PROTEUS vs

The ERS is dedicated to sharing scientific knowledge, fighting lung disease and promoting lung healt...

222 employees
Health Care
PROTEUS vs
Erasmus MC
Erasmus MC The Netherlands

Voor een gezonde toekomst

14336 employees
Health Care

FAQ About PROTEUS

Proteus, an interdisciplinary research collaboration based in Edinburgh, is revolutionizing lung disease treatment in ICUs.
PROTEUS was founded in 2014.
PROTEUS is headquartered in Edinburgh, United Kingdom.
PROTEUS operates in Health Care. Its work centres on interdisciplinary research, lung disease, ICU treatment and medical research.
PROTEUS has completed 1 funding round, raising a total of $1.12M. The latest funding stage is Grant.
Top alternatives and competitors to PROTEUS include Invizius, European Respiratory Society, Erasmus MC, Breathe Technologies, Inc., Poltreg. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PROTEUS and Invizius are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PROTEUS, https://bouncewatch.com/company/proteus-1, updated 11 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes